[ad_1]
The artificial-intelligence trade has suffered a setback over the past couple of weeks. But it is not over yet, according to John Higgins, chief market economist at Capital Economics.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...